G1 Therapeutics to grow as it approaches filing NDA


Sailing toward a new drug application on a wave of positive data and skyrocketing stocks, one Triangle public company will also be bringing more hands on board.

Previous Nashville executive wants her new city to avoid Seattle's mistakes
Next UPMC responds to attorney general over consent decree